http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2599037-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_781058c6baa05fa598d77d50ce93ae4d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-50 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate | 2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a6e10ec074bf3f849115d4406c68aa4 |
| publicationDate | 2016-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2599037-C1 |
| titleOfInvention | Method of treating acute hepatitis b or c with severe clinical course |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine and concerns new therapeutic regimens of acute viral hepatitis treatment, making it possible to reduce duration of clinical manifestation and preventing transition in the chronic course of the disease. Method of treating acute hepatitis B or C with severe clinical course consists in intravenous drop introduction of preparation 2 times a week for three months, wherein first drop introduction is 4.0 ml of Laennek, dissolved in 250 ml of 0.9 % sodium chloride water solution or 5 % glucose solution, through ulnar vein for 1 hour 20 minutes, second and subsequent introductions consist 10.0 ml of Laennek, dissolved in 250 ml of 0.9 % saline solution through ulnar vein for 1.5 hours. n EFFECT: method of treating acute hepatitis B or C is disclosed. n 1 cl, 2 ex |
| priorityDate | 2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.